TFX Teleflex Incorporated

Teleflex Ranked a Best Place to Work by MedReps.com

Teleflex Ranked a Best Place to Work by MedReps.com

For the third consecutive year, Teleflex earned a top spot as a best place to work by United States sales professionals in the annual MedReps.com Best Places to Work Survey

WAYNE, Pa., Dec. 19, 2019 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, announced that it was named the winner of MedReps.com’s 9th Annual Best Places to Work 2020 survey for the Large Category Best Medical Device Companies and came in second in the Overall Category, covering Best Medical Device Companies, Best Pharma Companies and Best Biotech Companies. Feedback from survey respondents revealed, “Medical sales employees, both inside and outside of the Teleflex community, acknowledge the company’s positive culture and ability to empower employees to positively impact the world around them.” 

“We are honored to once again be named a winner of the prestigious Best Place to Work award in medical sales,” said Liam Kelly, President and Chief Executive Officer. “This award demonstrates our employees’ commitment to delivering safe and effective products to the marketplace and the value they place on their career at Teleflex. I am personally proud of all we have achieved as a company and our success would not be possible without the dedication and engagement of our workforce. They are the driving force in our mission to improve the health and quality of people’s lives,” Kelly added.

Teleflex’s sales force was highly engaged in sharing their experiences working for the company; the majority of Teleflex votes in the MedReps survey came from current employees. Cam Hicks, Vice President of Global Human Resources and Employee Communications noted, “The level of participation in the 2020 MedReps survey and the caliber of responses from our own employees speaks volumes about the culture we have built at Teleflex. We are an organization where employees are given opportunities to develop and excel. We provide interesting and challenging work where our people can truly make a difference,” Hicks said.

Teleflex is a company that thrives on shared values and our people are our greatest asset. Working together, these values allow us to produce outstanding products and services that genuinely make a difference to people's lives around the world. We strive to be the best we can be at work and in our communities. That is the Teleflex Advantage.

Click here to find out more:

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular access, interventional cardiology and radiology, anesthesia, emergency medicine, surgical, urology and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit .

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rüsch®, UroLift®, and Weck® – trusted brands united by a common sense of purpose.

Source:

Teleflex Incorporated

Jake Elguicze

Treasurer and Vice President, Investor Relations

610-948-2836

EN
19/12/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Teleflex Incorporated

Teleflex Incorporated: Update following revision of outlook to stable

Our credit view of this issuer reflects its very good liquidity and strong free cash flow, constrained by its highly competitive industry sector.

Teleflex Incorporated - September 2025 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Moody's Ratings revises Teleflex's outlook to stable, affirms Ba1 CFR,...

Moody's Ratings (Moody's) affirmed the ratings of Teleflex Incorporated ("Teleflex") including the Ba1 Corporate Family Rating (CFR), Ba1-PD Probability of Default Rating (PDR) and the Ba2 rating on the senior unsecured notes. The company's Speculative Grade Liquidity Rating (SGL) was unchanged at S...

 PRESS RELEASE

Teleflex Announces Sale of Acute Care, Interventional Urology, and OEM...

Teleflex Announces Sale of Acute Care, Interventional Urology, and OEM Businesses for $2.03 Billion Board of Directors authorizes new $1 billion share repurchase program WAYNE, Pa., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced it has entered into definitive agreements to sell the company’s Acute Care, Interventional Urology and OEM businesses to two buyers, Intersurgical® Ltd with respect to Acute Care and Interventional Urology, and Montagu and Kohlberg with respect to OEM, for a combined total of...

 PRESS RELEASE

Teleflex to Present at the Jefferies Global Healthcare Conference in L...

Teleflex to Present at the Jefferies Global Healthcare Conference in London WAYNE, Pa., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Management of Teleflex Incorporated (NYSE: TFX) is scheduled to speak at the Jefferies Global Healthcare Conference in London on Tuesday, November 18, 2025, at 10:00 a.m. (GMT). A live audio webcast of the conference presentation will be available on the investor section of the Teleflex website at . About Teleflex Incorporated As a global provider of medical technologies, Teleflex is driven by our purpose to improve the health and quality of people’s lives. Through ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch